Clinical Interpretation Questions
- Why might Candida results differ between the basic Gut Health Test and a qPCR Candida Add-on?
- Why is H. pylori difficult to detect via standard shotgun metagenomic stool testing?
- How does the Tiny Health Gut Health Test compare to targeted qPCR add-ons or standalone clinical assays for low-abundance targets?
- Why might a pathogen (like H. pylori) test positive on a standard clinical antigen/qPCR test but show 0% on a Tiny Health Shotgun Metagenomics report?
- What occult blood test methodology does Tiny Health use in the PRO Gut Health Test?
- Are there populations where this test isn't appropriate or requires special interpretation?
- How can diversity and species richness be optimal, but my patient is low in Bifidobacterium or Faecalibacterium?
- When should my patient be retested?
- How long should I suggest patients follow the actions?
- I don't understand "bile acid capacity."
- What should I do about uncommon pathogens like Vibrio?
- I don't understand functional capacity. What genes are you measuring?
- Why don't beta-glucuronidase and short-chain fatty acid values align when measuring functional capacity in comparison to output in stool chemistry?
- The results seem overwhelming. Where do I start?
- Zonulin TLDR: not a specific marker for intestinal permeability